Molecular mechanisms of portal vein tolerance

Hepatology Research

Volumn 38, Issue 5, 2008, Pages 441-449

  Watanabe, Tomohiro ^a,b   Kudo, Masatoshi ^b   Chiba, Tsutomu ^a   Wakatsuki, Yoshio ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Cytokine; Liver

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; ENDOTOXIN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL SELECTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOTHELIUM CELL; FOOD ALLERGY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE FLORA; KUPFFER CELL; LIVER CELL; LIVER FUNCTION; LIVER SINUSOID; LIVER TRANSPLANTATION; LYMPHOCYTOPOIESIS; NONHUMAN; PORTAL VEIN TOLERANCE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; STELLATE CELL;

EID: 42649140574     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00313.x     Document Type: Review

References (62)

1. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003; 3: 51-62.
2. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-8.
3. Callery MP, Kamei T, Flye MW. The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding. J Surg Res 1989; 46: 391-4.
4. Lau AH, Thomson AW. Dendritic cells and immune regulation in the liver. Gut 2003; 52: 307-14.
5. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
6. Strober W, Murray PJ, Kitani A et al. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006; 6: 9-20.
7. Watanabe T, Katsukura H, Chiba T et al. Periportal and sinusoidal liver dendritic cells suppressing T helper type 1-mediated hepatitis. Gut 2007; 56: 1445-51.
8. O'Connell PJ, Morelli AE, Logar AJ et al. Phenotypic and functional characterization of mouse hepatic CD8 alpha+ lymphoid-related dendritic cells. J Immunol 2000; 165: 795-803.
9. Abe M, Tokita D, Raimondi G et al. Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses. Eur J Immunol 2006; 36: 2483-93.
10. De Creus A, Abe M, Lau AH et al. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol 2005; 174: 2037-45.
11. Pillarisetty VG, Shah AB, Miller G et al. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J Immunol 2004; 172: 1009-17.
12. Watanabe T, Katsukura H, Shirai Y et al. A liver tolerates a portal antigen by generating CD11c cells, which select Fas Ligand Th2 cells via apoptosis. Hepatology 2003; 38: 403-12.
13. Pillarisetty VG, Miller G, Shah AB et al. GM-CSF expands dendritic cells and their progenitors in mouse liver. Hepatology 2003; 37: 641-52.
14. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007; 7: 610-21.
15. Lu L, Woo J, Rao AS et al. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 1994; 179: 1823-34.
16. Khanna A, Morelli AE, Zhong C et al. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo. J Immunol 2000; 164: 1346-54.
17. Lu L, Bonham CA, Liang X et al. Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol 2001; 166: 7042-52.
18. Knolle PA, Limmer A. Neighborhood politics: The immunoregulatory function of organ-resident liver endothelial cells. Trends Immunol 2001; 22: 432-7.
19. Knolle PA, Schmitt E, Jin S et al. Induction of cytokine production in naïve CD4 (+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology 1999; 116: 1428-40.
20. Uhrig A, Banafsche R, Kremer M et al. Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver. J Leukoc Biol 2005; 77: 626-33.
21. Knolle PA, Germann T, Treichel U et al. Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. J Immunol 1999; 162: 1401-7.
22. Onoe T, Ohdan H, Tokita D et al. Liver sinusoidal endothelial cells tolerize T cells across MHC barriers in mice. J Immunol 2005; 175: 139-46.
23. Limmer A, Ohl J, Kurts C et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 2000; 6: 1348-54.
24. Limmer A, Ohl J, Wingender G et al. Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance. Eur J Immunol 2005; 35: 2970-81.
25. Schumann J, Wolf D, Pahl A et al. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol 2000; 157: 1671-83.
26. Nishimura T, Ohta A. A critical role for antigen-specific Th1 cells in acute liver injury in mice. J Immunol 1999; 162: 6503-9.
27. Tsutsui H, Kayagaki N, Kuida K et al. Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 1999; 11: 359-67.
28. Erhardt A, Biburger M, Papadopoulos T et al. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 2007; 45: 475-85.
29. Iwai Y, Terawaki S, Ikegawa M et al. PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 2003; 198: 39-50.
30. Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 2001; 21: 311-35.
31. Winau F, Hegasy G, Weiskirchen R et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007; 26: 117-29.
32. Chen CH, Kuo LM, Chang Y et al. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 2006; 44: 1171-81.
33. Mayer L, Shao L. Therapeutic potential of oral tolerance. Nat Rev Immunol 2004; 4: 407-19.
34. Chen Y, Inobe J, Marks R et al. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995; 376: 177-80.
35. Sakaguchi S, Sakaguchi N, Asano M et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-64.
36. Chen Y, Kuchroo VK, Inobe J et al. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237-40.
37. Groux H, O'Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737-42.
38. Huang L, Soldevila G, Leeker M et al. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994; 1: 741-9.
39. Mehal WZ, Juedes AE, Crispe IN. Selective retention of activated CD8+ T cells by the normal liver. J Immunol 1999; 163: 3202-10.
40. Crispe IN, Dao T, Klugewitz K et al. The liver as a site of T-cell apoptosis: Graveyard, or killing field? Immunol Rev 2000; 174: 47-62.
41. Bowen DG, Zen M, Holz L et al. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 2004; 114: 701-12.
42. John B, Crispe IN. TLR-4 regulates CD8+T cell trapping in the liver. J Immunol 2005; 175: 1643-50.
43. Klugewitz K, Blumenthal-Barby F, Schrage A et al. Immunomodulatory effects of the liver: Deletion of activated CD4+ effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization. J Immunol 2002; 169: 2407-13.
44. Watanabe T, Yoshida M, Shirai Y et al. Administration of an antigen at a high dose generates regulatory CD4+ T cells expressing CD95 ligand and secreting IL-4 in the liver. J Immunol 2002; 168: 2188-99.
45. Sakaguchi S, Powrie F. Emerging challenges in regulatory T cell function and biology. Science 2007; 317: 627-9.
46. Cao O, Dobrzynski E, Wang L et al. Induction and role of regulatory CD4+ CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer. Blood 2007; 110: 1132-40.
47. Dobrzynski E, Mingozzi F, Liu YL et al. Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer. Blood 2004; 104: 969-77.
48. Lan RY, Cheng C, Lian ZX et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 2006; 43: 729-37.
49. Longhi MS, Ma Y, Bogdanos DP et al. Impairment of CD4 (+) CD25 (+) regulatory T-cells in autoimmune liver disease. J Hepatol 2004; 41: 31-7.
50. Demirkiran A, Bosma BM, Kok A et al. Allosuppressive donor CD4+CD25+ regulatory T cells detach from the graft and circulate in recipients after liver transplantation. J Immunol 2007; 178: 6066-72.
51. Triger DR, Alp MH, Wright R. Bacterial and dietary antibodies in liver disease. Lancet 1972; 1: 60-3.
52. Fuss IJ, Marth T, Neurath MF et al. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology 1999; 117: 1078-88.
53. Yoshimoto T, Mizutani H, Tsutsui H et al. IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol 2000; 1: 132-7.
54. Berg M, Wingender G, Djandji D et al. Cross-presentation of antigens from apoptotic tumor cells by liver sinusoidal endothelial cells leads to tumor-specific CD8+T cell tolerance. Eur J Immunol 2006; 36: 2960-70.
55. Sicherer S. Food allergy. Lancet 2002; 360: 701.
56. Kweon MN, Yamamoto M, Kajiki M et al. Systemically derived large intestinal CD4 (+) Th2 cells play a central role in STAT6-mediated allergic diarrhea. J Clin Invest 2000; 106: 199-206.
57. Snider DP, Marshall JS, Perdue MH et al. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J Immunol 1994; 153: 647-57.
58. Finkelman FD, Katona IM, Urban JF et al. IL-4 is required to generate and sustain in vivo IgE responses. J Immunol 1988; 141: 2335-41.
59. Watanabe T, Katsukura H, Shirai Y et al. Helper CD4 T cells for IgE response to a dietary antigen develop in the liver. J Allergy Clin Immunol 2003; 111: 1375-85.
60. Ito K, Inagaki-Ohara K, Murosaki S et al. Murine model of IgE production with a predominant Th2-response by feeding protein antigen without adjuvants. Eur J Immunol 1997; 27: 3427-37.
61. Collins AM, Leach S, Payne J et al. A role for the hepatobiliary system in IgE-mediated intestinal inflammation in the rat. Clin Exp Allergy 1999; 29: 262-70.
62. Legendre C, Caillat-Zucman S, Samuel D et al. Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant. N Engl J Med 1997; 337: 822-4.